Treatments administered to the first 9152 reported cases of COVID-19: a systematic review

DC Fajgenbaum, JS Khor, A Gorzewski… - Infectious diseases and …, 2020 - Springer
The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global
pandemic with no approved treatments or vaccines. Many treatments have already been …

[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics

D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …

[HTML][HTML] Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the …

M Falavigna, V Colpani, C Stein… - Revista Brasileira de …, 2020 - SciELO Brasil
Introdução: Há diversas terapias sendo utilizadas, consideradas ou propostas para o
tratamento da COVID-19, muitas carecendo de apropriada avaliação de efetividade e …

[HTML][HTML] COVID-19: Clinical aspects and therapeutics responses

S Khan, A Ali, H Shi, R Siddique, G Nabi, J Hu… - Saudi Pharmaceutical …, 2020 - Elsevier
COVID-19 has created havoc in the world by causing thousands of demises in a short period
of time. Up till now, several attempts have been made for potential therapeutics against …

Therapeutic strategies for COVID-19: progress and lessons learned

G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019

A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …

Emerging treatment strategies for COVID-19 infection

M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …

[PDF][PDF] COVID-19 drug therapy

T Smith, J Bushek, A LeClaire, T Prosser - Elsevier, 2020 - repository.phb.ac.id
• There are no specific therapies approved by the US Food and Drug Administration (FDA)
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes …

Drug treatments for covid-19: living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

COVID-19: a review of potential treatments (corticosteroids, remdesivir, tocilizumab, bamlanivimab/etesevimab, and casirivimab/imdevimab) and pharmacological …

S Nhean, ME Varela, YN Nguyen… - Journal of …, 2023 - journals.sagepub.com
Objectives: In light of the ongoing global pandemic, this paper reviews data on a number of
potential and approved agents for COVID-19 disease management, including …